Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.

Source:http://linkedlifedata.com/resource/pubmed/id/18448455

Download in:

View as

General Info

PMID
18448455